The gut microbiome influences host endocrine functions.

  title={The gut microbiome influences host endocrine functions.},
  author={Marialetizia Rastelli and Patrice D Cani and Claude Knauf},
  journal={Endocrine reviews},
The gut microbiome is now considered as an organ contributing to the regulation of host metabolism. Since the finding of the existence of a relationship between the gut microbiome and specific diseases, numerous studies have also deciphered molecular mechanisms explaining how gut bacteria dialogue with host cells and eventually shape metabolism. Both metagenomic and metabolomic analyses have contributed to the discovery of bacterial-derived metabolites acting on host cells. In this review, we… 
Gut microbiome and health: mechanistic insights
Understanding the complexity and the molecular aspects linking gut microbes to health will help to set the basis for novel therapies that are already being developed, according to a critical evaluation of the current understanding.
Gut microbiome, endocrine control of gut barrier function and metabolic diseases.
The role of specific dietary compounds or nutrients as well as different metabolites produced by the microbiota in host metabolism are examined and how they control several endocrine functions and eventually have either beneficial or deleterious effects on host health are discussed.
Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology.
Microbiome mediation of animal life histories via metabolites and insulin‐like signalling
Known and hypothesized pathways by which gut microbiota influence host life histories through interfacing with the neuroendocrine system are reviewed, with a focus on the insulin‐like growth factor (IGF) signalling pathway.
The microbiota–gut–brain axis: A novel nutritional therapeutic target for growth retardation
The role of microbiota in GR is summarized with human and animal models, and nutritional therapeutic strategies by the intervention of microbiota-gut-brain axis are proposed, which may provide novel perspectives for the treatment of GR in humans and animals.
Growth hormone deficiency and excess alter the gut microbiome in adult male mice.
This study is the first to characterize the gut microbiome in mouse lines with altered GH action and indicates that GH may play a role in the growth of certain microbiota thus impacting microbial maturation and metabolic function.
Human Gut Microbiome as an Indicator of Human Health
This review is dedicated to the analysis of the possibilities of application of the human gut microbiome for the diagnosis of diseases, and the role of the intestines in the provocation and causing of certain diseases.
Gut Microbiota and Endocrine Disorder.
This chapter provides a comprehensive overview of the biological mechanisms of gut microbiota that participate in endocrine system pathologies and discusses potential novel therapies for these diseases.


Endocannabinoids — at the crossroads between the gut microbiota and host metabolism
The gut microbiota as well as the endocannabinoid system and associated bioactive lipids are defined and gut-barrier function is highlighted by discussing the role of specific factors considered to be putative 'gate keepers' or 'gate openers', and their role in the gut microbiota–endocannabinoids system axis.
Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health
The role for gut microbiota-generated SCFA in protecting against the effects of energy dense diets offers an intriguing new avenue for regulating metabolic health and CVD risk.
Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue.
  • Patrice D Cani
  • Biology, Medicine
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2012
The role of prebiotics as a key tool to modulate the gut microbiota, the gut barrier function, inflammation and the insulin resistance associated with obesity is discussed.
Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes
Gut microbiota modulate metabotype expression at both local (gut) and global (biofluids, kidney, liver) system levels and hence influence the responses to a variety of dietary modulation and drug exposures relevant to personalized health‐care investigations.
Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions
Several of the most intriguing diet-dependent metabolites that may impact host physiology and may therefore be appropriate targets for therapeutic interventions, such as short-chain fatty acids, trimethylamine N-oxide, tryptophan and tyrosine derivatives, and oxidized fatty acids are reviewed.
A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites
This work uses a combination of genetics and metabolic profiling to characterize a pathway from the gut symbiont Clostridium sporogenes that generates aromatic amino acid metabolites, and reveals that this pathway produces twelve compounds, nine of which are known to accumulate in host serum.
Human gut microbiome: hopes, threats and promises
Recent evidence of the impact of the gut microbiota on metabolic disorders and focus on selected key mechanisms is discussed and the cases of the bacteria Prevotella copri and Akkermansia muciniphila will be discussed as key examples.